Navigation Links
LA BioMed President and CEO will be named president of the American Judicature Society
Date:7/9/2009

LOS ANGELES (July 8, 2009) Carole Wagner Vallianos, Esq., president and CEO of the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), will be inaugurated as the president of the American Judicature Society at its Annual Meeting in Chicago on July 30.

Founded in 1913, the American Judicature Society is an independent, national, nonpartisan organization of judges, lawyers and other members of the public who seek to improve the justice system. The society, which brings a public perspective to justice system issues, has the mission to secure and promote an independent and qualified judiciary and a fair system of justice.

Wagner Vallianos will take over the post from the current president, Gordon L. Doerfer of Boston, MA. Doerfer, who served 25 years on the trial and appellate courts of Massachusetts, is a mediator and arbitrator on the panel of neutrals at JAMS The Resolution Experts.

"I am honored and excited to have this opportunity to serve as president of the American Judicature Society, an organization dedicated to improving and promoting a fair system of justice," said Wagner Vallianos. "I look forward to working with my colleagues in a collaborative and coordinated effort to strengthen the American Judicature Society and the judiciary."

Wagner Vallianos became president and CEO of LA BioMed in September 2008, after serving six years on the institute's board of directors, including two years as the board's chair. She had also served as the board's treasurer and chair of the board's finance committee.

She is a principal in the Law Offices of Carole Wagner Vallianos, a Manhattan Beach firm where she practices civil rights, nonprofit corporation law and estate planning. She was reappointed to the California Judicial Council's Standing Committee on Access and Fairness in the Courts and is a past member of the Jury Improvement Task Force and the Council's Advisory Committees on Race and Ethics Bias in the Courts and Private Judging.

Wagner Vallianos also is a Fellow of the California First Amendment Coalition and a former advisory board member of the Citizen Access Project, University of Florida's Brechner Center for Freedom of Information.

In addition, she is a member of Women Lawyers of Los Angeles, the South Bay Bar Association and the Benjamin Aranda III Inn of Court. She is past president of the League of Women Voters of California, and she was on the Board of Directors of the League of Women Voters of the United States and the Board of Trustees of the League of Women Voters Education Fund.

She has served as an NGO/nonprofit consultant with the U.S. Department of State in Bosnia, Turkey, Cyprus and India. She is a graduate of Coro, a public policy training program, and is a member of Pacific Council on International Policy. Wagner Vallianos received her B.A. from California State University, Fullerton, and her J.D. from Southwestern University School of Law.


'/>"/>

Contact: Laura Mecoy
Lmecoy@issuesmanagement.com
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert  

Related medicine news :

1. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
2. Biomedtex Inc. Announces A. Marc Rocca as President and CEO
3. Hopes, Predictions and Realities: Is Biomedical Research Delivering On Its Promises?
4. Dr. Andrew K. Palmer Joins BMEs (BioMedical Enterprises, Inc.) Board of Directors
5. BioMed Realty Trust to Report 2007 Third Quarter Results
6. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSArc(TM) Anatomic Residual Compression Implant
7. Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange
8. BioMed Realty Trust Reports Third Quarter 2007 Financial Results
9. LA BioMed research finds simpler way to assess breast cancer risk
10. LA BioMed researchers find few emergency rooms fully equipped for pediatric patients
11. BioMed Realty Trust Declares Fourth Quarter 2007 Common Stock and Preferred Stock Dividends
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
LA BioMed President and CEO will be named president of the American Judicature Society
(Date:2/19/2017)... ... ... Braun Industries will be participating as an exhibitor at EMS Today 2017. ... 23-25, 2017 at the Calvin L. Rampton Salt Palace Convention Center in Salt Lake ... on display. , “JEMS is a leader in EMS news and education. ...
(Date:2/19/2017)... ... February 19, 2017 , ... ... in better care, and MEDfx and the Delaware Health Information Network (DHIN) have ... As the nation’s first state-wide health information exchange, DHIN stores and shares real-time ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... Axendia, **FDAnews Free Webinar**, March 1, 2017 — 1:30 p.m. – 2:30 ... regulatory burden? Pay dividends in enhanced and predictable product performance? Streamline processes ...
(Date:2/18/2017)... ... 17, 2017 , ... Butler Mobility invited Ken Matthews to visit its manufacturing ... Ken was impressed with the safety and reliability of the Stannah Stairlift as ... show. This endorsement by Ken Matthews can be heard on News Radio WHP ...
(Date:2/18/2017)... ... February 17, 2017 , ... Park Cities Pet Sitter ... Show on the Pet Life Radio network. The episode, which was posted this ... topics including: what factors led to Park Cities Pet Sitter’s being awarded the 2017 ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... Research and Markets has announced the addition of ... report to their offering. ... Traditional medical devices include devices (e.g., ... implantables, large endoscopes, needle based drug delivery, lab based diagnostics ... to three decades for the treatment and management of various ...
(Date:2/16/2017)... -- DaVita Inc. (NYSE: DVA ) today announced ... Net income attributable to DaVita Inc. for ... million, or $0.80 per share and $880 million, or $4.29 ... to DaVita Inc. for the quarter and year ended December ... million, or $0.98 per share, and $789 million, or $3.85 ...
(Date:2/16/2017)... 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... today announced that executive management will participate in the ... February 22-23, 2017. Adrian Adams , Chief Executive ... 1:35 p.m. local time on Wednesday, February 22, 2017. ... the event may be accessed from the Investors section ...
Breaking Medicine Technology: